Metraipolis › archive › dc_fa2f13c2ef91

Integrative In Silico Identification of TP53-Associated Drug Repurposing Candidates in Lung Adenocarcinoma — Europe PMC PMID:42198435

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42198435
DOI: 10.3390/ph19050761
License (as archived): solo-consultazione
Archived: 2026-11-02T10:53:46.255Z
SHA-256 of the archived text: ff4820e6672f7b851b8c7af4ce3bb1343f8550edd400f076d8629eb40359591f
Stable URL of this page: https://metraipolis.com/documento/dc_fa2f13c2ef91

How to cite

Integrative In Silico Identification of TP53-Associated Drug Repurposing Candidates in Lung Adenocarcinoma — Europe PMC PMID:42198435 — Europe PMC (en), https://europepmc.org/article/MED/42198435 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa2f13c2ef91 (Metraipolis archive dc_fa2f13c2ef91, sha256 ff4820e6672f7b851b8c7af4ce3bb1343f8550edd400f076d8629eb40359591f)

BibTeX

@misc{dcfa2f13c2ef91,
  title = {Integrative In Silico Identification of TP53-Associated Drug Repurposing Candidates in Lung Adenocarcinoma — Europe PMC PMID:42198435},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198435},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa2f13c2ef91; sha256 ff4820e6672f7b851b8c7af4ce3bb1343f8550edd400f076d8629eb40359591f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198435. Agents can read the archived copy with the MCP tool read_document.